INDAPTUS THERAPEUTICS INC (INDP)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.22+5.17%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · INDP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 5.2 | 9.3 | 7.3 | 7.6 | 6.3 | 2.5 | 2.7 |
| Other Operating Expenses, Total | — | 0.1 | 0.3 | 1.0 | — | — | — |
| Operating Income | (14.8) | (19.8) | (15.4) | (16.4) | (14.9) | (7.7) | (3.6) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | — | — | 0.3 | 1.0 | 0.6 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | — | (20.8) | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (15.4) | (20.8) | (15.0) | (15.4) | (14.3) | (7.7) | (3.6) |
| Per Share | |||||||
| Basic EPS | (0.13) | (21.58) | (1.61) | (1.83) | (1.73) | (1.89) | — |
| Diluted EPS | (0.13) | (21.58) | (1.61) | (1.83) | (1.73) | — | — |
| Basic Weighted Avg Shares | 116.1 | 1.0 | 9.4 | 8.4 | 8.3 | 4.1 | — |
| Diluted Weighted Avg Shares | 116.1 | 1.0 | 9.4 | 8.4 | 8.3 | — | — |
| Supplemental | |||||||
| EBIT | (14.8) | (19.8) | (15.4) | (16.4) | (14.9) | (7.7) | (3.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.